首頁 > 市場調查報告書 > 製藥

眼科藥物

市場調查報告書

商品編碼

1423307

2024-2032 年按疾病類型、藥物類型、產品、配銷通路和地區分類的乾眼症市場報告

Dry Eye Syndrome Market Report by Disease Type, Drug Type, Product, Distribution Channel, and Region 2024-2032

出版日期: 2024年01月30日 | 出版商:

IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年全球乾眼症市場規模達48億美元。展望未來， IMARC Group預計到2032年市場規模將達到75億美元，2024-2032年複合年成長率（CAGR）為5%。老年人口的增加、各年齡層的螢幕時間增加、環境污染加劇、診斷技術的最新進步、消費者醫療保健支出的增加、大眾意識的提高以及線上零售業的擴張是推動市場的一些主要因素。

乾眼症是指影響眼睛產生足夠眼淚以潤滑和滋養的能力的醫療狀況。當身體試圖抵消乾燥時，它會引起各種症狀，例如發紅、刺激、沙礫感和流淚。乾眼症是透過測量淚液產生和眼睛表面品質的多項測試來診斷的。其治療方法包括非處方（OTC）人工淚液、處方藥和手術干預（例如淚點塞）。這些治療有助於減輕不適、增強視覺清晰度、改善整體眼睛健康並提高患者的生活品質。

診斷技術的最新進步使得乾眼症的識別更加精確和早期，正在推動市場成長。此外，消費者醫療保健支出的不斷成長表明了對眼睛健康的投資意願，這是另一個促進成長的因素。此外，大眾意識的提高，導致有關眼睛健康問題的自我診斷和專業諮詢的增加，對市場成長產生了積極影響。此外，快速的全球化和都市化導致生活方式的改變，有利於眼睛疲勞和乾眼症，有利於市場成長。此外，線上零售業的擴張使人們更容易獲得非處方藥治療，從而擴大了消費者基礎，正在促進市場成長。同時，手術治療（例如雷射手術）的可用性和負擔能力的不斷提高正在支持市場的成長。

乾眼症市場趨勢/促進因素：

老年人口不斷增加

老年人口的增加是市場成長的重要驅動力。由於自然老化過程會影響眼睛產生足夠眼淚的能力，乾眼症在老年族群中更為常見。此外，全球各國的預期壽命正在增加，這反過來又增加了老年人口。這種轉變對與年齡相關的疾病（包括乾眼症）的盛行率有直接影響。除此之外，老年人更容易罹患慢性疾病，而治療這些疾病的藥物通常會產生副作用，加劇乾眼症狀。因此，醫療保健系統面臨著對乾眼症診斷服務和治療的需求不斷增加，例如潤滑眼藥水、處方藥和專門的眼部護理服務。

不同年齡層的螢幕時間不斷增加

各個年齡層的螢幕時間不斷增加是推動乾眼症市場的重要因素。現代生活方式越來越依賴數位螢幕，例如智慧型手機、平板電腦和電腦顯示器。此外，新興的遠距工作文化增加了員工接觸數位螢幕的時間，這減少了眨眼的頻率，導致眼睛乾燥。除此之外，多項研究表明，年輕人螢幕時間增加與乾眼症症狀之間存在密切關聯。因此，針對數位眼疲勞引起的乾眼症的治療需求不斷增加，導致消費者在非處方 (OTC) 人工淚液、處方治療和旨在減輕數位眼疲勞的設備上的支出增加。

環境污染日益嚴重

環境因素在乾眼症市場的擴大中也扮演著重要角色。快速工業化地區的空氣污染和極端天氣條件正在加劇乾眼症的症狀。與此一致的是，空氣污染顆粒會引起刺激，並且通常對眼睛脆弱的組織有毒，誘發或加重乾眼症狀。此外，各種室內污染物，包括清潔產品、油漆和其他家居用品排放的揮發性有機化合物 (VOC)，會降低室內空氣質量，導致眼睛刺激和乾燥。除此之外，污染環境引起的過敏反應可能會引發易過敏人群的乾眼症狀。此外，環境污染會導致氣候變化，從而改變天氣模式和濕度水平。這些變化顯著影響淚液蒸發率並加劇乾眼症狀，尤其是在乾旱地區。

Abstract

The global dry eye syndrome market size reached US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. The rising geriatric population, escalating screen time among various age groups, increasing environmental pollution, recent advancements in diagnostic techniques, rising consumer healthcare spending, heightened awareness among the masses, and expansion of the online retail sectors are some of the major factors propelling the market.

Dry eye syndrome refers to a medical condition affecting the eyes' ability to produce adequate tears for lubrication and nourishment. It causes various symptoms, such as redness, irritation, a gritty feeling, and watery eyes as the body tries to counteract the dryness. Dry eye syndrome is diagnosed through multiple tests that measure tear production and eye surface quality. Its treatment involves over-the-counter (OTC) artificial tears, prescription medications, and surgical interventions, such as punctual plugs. These treatments aid in alleviating discomfort, enhancing visual clarity, improving overall eye health, and augmenting patient's quality of life.

The recent advancement in diagnostic techniques, which have enabled more precise and earlier identification of dry eye syndrome, is propelling the market growth. Additionally, the rising consumer healthcare spending, which showcases willingness to invest in eye health, is acting as another growth-inducing factor. Furthermore, the heightened awareness among the masses, leading to an increase in self-diagnosis and professional consultations regarding eye health issues, is positively influencing the market growth. In addition, the rapid globalization and urbanization, which have caused lifestyle changes that are conducive to eye strain and dry eye conditions, are favoring the market growth. Moreover, the expansion of the online retail sector, which provides easier access to OTC treatments, thus broadening the consumer base, is catalyzing the market growth. Along with this, the increasing availability and affordability of surgical treatments, such as laser procedures, is supporting the market growth.

Dry Eye Syndrome Market Trends/Drivers:

The rising geriatric population

The rising geriatric population is an important driver for the market growth. Dry eye syndrome is more common in the geriatric population due to the natural aging process, which impacts the eye's ability to produce sufficient tears. Furthermore, countries across the globe are experiencing an increase in life expectancy, which, in turn, is increasing the geriatric population. This shift has a direct impact on the prevalence of age-related medical conditions, including dry eye syndrome. Besides this, geriatric adults are more susceptible to chronic health illnesses, and medications used for these conditions often have side effects that exacerbate dry eye symptoms. As a result, healthcare systems are facing an increased demand for both diagnostic services and treatments for dry eye syndrome, such as lubricating eye drops, prescription medications, and specialized eye care services.

The escalating screen time among various age groups

The escalating screen time across various age groups is a substantial factor fueling the dry eye syndrome market. Modern lifestyles are increasingly dependent on digital screens, such as smartphones, tablets, and computer monitors. Furthermore, the emerging remote working culture has extended the exposure of employees to digital screens, which decreases the frequency of blinking, causing dryness in the eyes. Besides this, several studies have indicated a strong association between heightened screen time and symptoms of dry eye syndrome among young adults. Therefore, the escalating need for treatments targeting digital eye strain-induced dry eye is contributing to increased consumer spending on over-the-counter (OTC) artificial tears, prescription treatments, and devices designed to reduce digital eye strain.

The increasing environmental pollution

Environmental factors also play an important role in the expansion of the dry eye syndrome market. Polluted air and extreme weather conditions in rapidly industrializing regions are exacerbating the symptoms of dry eye syndrome. In line with this, air pollution particles cause irritation and are often toxic to the eye's delicate tissues, thus inducing or aggravating dry eye symptoms. Furthermore, various indoor pollutants, including volatile organic compounds (VOCs) emitted from cleaning products, paints, and other household items, reduce indoor air quality and lead to eye irritation and dryness. Besides this, allergic reactions from polluted environments can trigger dry eye symptoms in individuals who are susceptible to allergies. Moreover, environmental pollution contributes to climate change, which can alter weather patterns and humidity levels. These changes significantly affect tear evaporation rates and exacerbate dry eye symptoms, especially in arid regions.

Dry Eye Syndrome Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global dry eye syndrome market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on disease type, drug type, product, and distribution channel.

Breakup by Disease Type:

Evaporative Dry Eye Syndrome

Aqueous Dry Eye Syndrome

Evaporative dry eye syndrome dominates the market

The report has provided a detailed breakup and analysis of the market based on disease type. This includes evaporative dry eye syndrome and aqueous dry eye syndrome. According to the report, evaporative dry eye syndrome represented the largest segment.

Evaporative dry eye syndrome is dominating the market due to its higher prevalence compared to other types of dry eye syndrome. In this condition, the tear film's lipid layer is compromised, causing faster evaporation of tears, resulting in dryness and irritation. Furthermore, the rising lifestyle-related issues, such as prolonged digital screen usage, exacerbate the symptoms of evaporative dry eye, making it more common among both younger and geriatric populations. Additionally, the recent technological advancements, which have made the diagnosis of evaporative dry eye more straightforward and cost-effective, are contributing to the market growth. Besides this, evaporative dry eye tends to have more chronic and pronounced symptoms, making patients more likely to seek medical interventions and opt for various treatment modalities.

Breakup by Drug Type:

Anti-inflammatory Drugs

Lubricant Eye Drops

Autologous Serum Eye Drops

Anti-inflammatory drugs hold the largest share in the market

A detailed breakup and analysis of the market based on drug type has also been provided in the report. This includes anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops. According to the report, anti-inflammatory drugs represented the largest segment.

Anti-inflammatory drugs are dominating the market due to their effectiveness in treating the underlying inflammation associated with dry eye conditions. These drugs act by reducing the inflammation on the eye's surface and tear glands, offering immediate relief and promoting long-term healing. Additionally, they are suitable for treating both aqueous-deficient and evaporative types of dry eye, making them a go-to choice for healthcare providers. Furthermore, anti-inflammatory drugs have a quick onset of action and can be self-administered, making them a preferred choice for those seeking rapid and convenient relief. Besides this, continuous research and development (R&D) in anti-inflammatory medications, leading to the formulation of drugs with fewer side effects and longer-lasting relief, is contributing to the market growth.

Breakup by Product:

Liquid Drops

Gel

Liquid Wipes

Eye Ointment

Others

Liquid drops hold the largest share in the market

A detailed breakup and analysis of the market based on product has also been provided in the report. This includes liquid drops, gel, liquid wipes, eye ointment, and others. According to the report, liquid drops accounted for the largest market share.

Liquid eye drops are dominating the market as they can be quickly and easily administered by patients themselves, providing immediate relief from symptoms. This user-friendly aspect boosts their appeal, especially for people seeking a convenient and fast-acting solution to their eye discomfort. Furthermore, compared to other treatment options such as prescription drugs, surgical interventions, or specialized medical devices, OTC liquid eye drops are generally more affordable, which makes them accessible to a broader population. Additionally, liquid eye drop formulations often include lubricants, electrolytes, and occasionally anti-inflammatory or anti-allergic components that address multiple symptoms at once. Besides this, the small packaging of liquid eye drops allows users to apply them wherever and whenever symptoms arise. This convenience enhances user compliance, making it more likely for patients to adhere to treatment plans.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Hospital pharmacies hold the largest share in the market

A detailed breakup and analysis of the market based on distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies accounted for the largest market share.

Hospital pharmacies are dominating the market due to the trust and credibility associated with hospital-based healthcare. Patients often prefer medications and treatments prescribed and dispensed within the same healthcare ecosystem, assuming a higher standard of quality and safety. Besides this, proximity to healthcare professionals provides the ability to fill prescriptions immediately following a consultation or procedure, which is highly appealing to both patients and caregivers. Additionally, hospital pharmacies have a comprehensive inventory of medications, including specialized formulations that might not be readily available at retail or online platforms. Moreover, they have trained healthcare professionals, including pharmacists specialized in ophthalmology, which ensures that patients receive expert advice on medication administration, side effects, and other treatment-related queries.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest dry eye syndrome market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America has an advanced healthcare infrastructure, which ensures easy access to specialized eye care facilities and experienced professionals. Moreover, the high standard of care encourages timely diagnosis and effective treatment, thereby boosting the market growth. Additionally, the increasing healthcare expenditure in the region, which allows individuals to seek professional medical advice and opt for advanced treatment options, is contributing to the market growth. Furthermore, the region is a hub for pharmaceutical innovation and development, which results in the early availability of new treatments and medications. Apart from this, North America has a well-regulated pharmaceutical industry, with stringent guidelines governing the safety and efficacy of medical products, including those for treating dry eye syndrome. Moreover, the escalating geriatric population, which is highly susceptible to dry eye syndrome, is favoring the market growth.

Competitive Landscape:

Leading players are heavily investing in creating new formulations, devices, and treatment methods to address different forms of dry eye syndrome more effectively. Furthermore, they are working with research institutions, other pharmaceutical companies, and healthcare providers to accelerate the development of new products and extend their market reach. Besides this, top firms are acquiring smaller companies with innovative technologies to diversify their product portfolio quickly and gain a competitive advantage. Additionally, companies are developing educational campaigns aimed at both healthcare providers and the general public to raise awareness regarding the importance of early diagnosis and effective treatment. Moreover, they are setting up manufacturing units, distribution channels, and partnerships to tap into the growing demand for dry eye treatments in various geographical regions.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Akorn Operating Company LLC

Alimera Science

Allergan plc.

Auven Therapeutics

Bausch + Lomb Incorporated

GlaxoSmithKline plc

Nicox S.A.

Novartis AG

Otsuka Holdings Co., Ltd.

Santen Pharmaceutical Co., Ltd.

Recent Developments:

In March 2022, Thea, a US-based eye care product company, completed the acquisition of multiple ophthalmic products from Akorn Operating Company LLC.

In September 2021, Bausch + Lomb Incorporated collaborated with Novaliq Gmbh to develop a new drug, NOV03, for the treatment of dry eye disease.

In August 2022, Nicox S.A. announced that it will be working on the development of NCX 4251 as a treatment for dry eye disease.

Key Questions Answered in This Report

1. What was the size of the global dry eye syndrome market in 2023?
2. What is the expected growth rate of the global dry eye syndrome market during 2024-2032?
3. What are the key factors driving the global dry eye syndrome market?
4. What has been the impact of COVID-19 on the global dry eye syndrome market?
5. What is the breakup of the global dry eye syndrome market based on the disease type?
6. What is the breakup of the global dry eye syndrome market based on the drug type?
7. What is the breakup of the global dry eye syndrome market based on the product?
8. What is the breakup of the global dry eye syndrome market based on the distribution channel?
9. What are the key regions in the global dry eye syndrome market?
10. Who are the key companies/players in the global dry eye syndrome market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Dry Eye Syndrome Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Disease Type
5.5 Market Breakup by Drug Type
5.6 Market Breakup by Product
5.7 Market Breakup by Distribution Channels
5.8 Market Breakup by Region
5.9 Market Forecast

6 Market Breakup by Disease Type

6.1 Evaporative Dry Eye Syndrome
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Aqueous Dry Eye Syndrome
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Drug Type

7.1 Anti-inflammatory Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Lubricant Eye Drops
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Autologous Serum Eye Drops
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Product

8.1 Liquid Drops
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Gel
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Liquid Wipes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Eye Ointment
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Online Pharmacies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Europe
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Asia Pacific
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Middle East and Africa
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
10.5 Latin America
- 10.5.1 Market Trends
- 10.5.2 Market Forecast

11 Global Dry Eye Syndrome Industry: SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Global Dry Eye Syndrome Industry: Value Chain Analysis

13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Global Dry Eye Syndrome Industry: Price Analysis

14.1 Price Indicators
14.2 Price Structure
14.3 Margin Analysis

15 Manufacturing Process

15.1 Product Overview
15.2 Raw Material Requirements
15.3 Manufacturing Process
15.4 Key Success and Risk Factors

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Akorn Operating Company LLC
- 16.3.2 Alimera Science
- 16.3.3 Allergan plc.
- 16.3.4 Auven Therapeutics
- 16.3.5 Bausch + Lomb Incorporated
- 16.3.6 GlaxoSmithKline plc
- 16.3.7 Nicox S.A.
- 16.3.8 Novartis AG
- 16.3.9 Otsuka Holdings Co., Ltd.
- 16.3.10 Santen Pharmaceutical Co., Ltd.

簡介目錄圖表

List of Figures

Figure 1: Global: Dry Eye Syndrome Market: Major Drivers and Challenges
Figure 2: Global: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2023
Figure 4: Global: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2023
Figure 5: Global: Dry Eye Syndrome Market: Breakup by Product (in %), 2023
Figure 6: Global: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Dry Eye Syndrome Market: Breakup by Region (in %), 2023
Figure 8: Global: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 9: Global: Dry Eye Syndrome (Evaporative) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Dry Eye Syndrome (Evaporative) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Dry Eye Syndrome (Aqueous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Dry Eye Syndrome (Aqueous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Dry Eye Syndrome (Gel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Dry Eye Syndrome (Gel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Dry Eye Syndrome (Eye Ointment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Dry Eye Syndrome (Eye Ointment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Dry Eye Syndrome (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Dry Eye Syndrome (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Dry Eye Syndrome (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Dry Eye Syndrome (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Dry Eye Syndrome (Retail) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Dry Eye Syndrome (Retail) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Dry Eye Syndrome (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Dry Eye Syndrome (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: North America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: North America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Europe: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Europe: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Asia Pacific: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Asia Pacific: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Middle East and Africa: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Middle East and Africa: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Latin America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Latin America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Dry Eye Syndrome Industry: SWOT Analysis
Figure 46: Global: Dry Eye Syndrome Industry: Value Chain Analysis
Figure 47: Global: Dry Eye Syndrome Industry: Porter's Five Forces Analysis
Figure 48: Dry Eye Syndrome Manufacturing: Process Flow

List of Tables

Table 1: Global: Dry Eye Syndrome Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Dry Eye Syndrome Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
Table 3: Global: Dry Eye Syndrome Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 4: Global: Dry Eye Syndrome Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 5: Global: Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Dry Eye Syndrome Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Dry Eye Syndrome: Raw Material Requirements
Table 8: Global: Dry Eye Syndrome Market Structure
Table 9: Global: Dry Eye Syndrome Market: Key Players

02-2729-4219

+886-2-2729-4219